WASHINGTON, Jan. 31, 2026 /PRNewswire/ — Capstone LLC, a leading policy analysis and investment research firm, has released its healthcare sector preview for 2026, identifying key policy and regulatory developments expected to drive investment opportunities across providers, payors, pharmaceuticals, and health information technology.
Capstone expects Medicare Advantage carriers to benefit from program stability under the Trump administration, while payors exposed to Affordable Care Act exchanges and Medicaid face headwinds from subsidy reforms and potential expiration. Medicaid-exposed providers will encounter incremental challenges as rate growth remains constrained despite relatively strong state budgets.
The firm anticipates 2026 will mark a fundamental shift in pharmaceutical economics, with policy interventions redistributing value across the supply chain. Pharmacies and wholesalers face margin compression while drugmakers pursue leverage through Most Favored Nation frameworks, creating execution risk amid untested systems and regulatory uncertainty.
Healthcare information technology opportunities will be shaped by converging pressures from litigation, regulatory deadlines, and legislation. Information blocking enforcement favors analytics vendors, FHIR API mandates drive interoperability procurement, and Medicaid work requirements create tailwinds for eligibility and revenue cycle management solutions.
In Europe, Trump administration tariff threats may push modest drug price increases, while pharmaceutical reform advances with mixed sector implications.
Please access the following links to read Capstone’s outlook on developments for 2026:
For more information contact Daniel Kruger by phone at (917) 566-8220 or E-mail: news@capstonedc.com
About Capstone
Capstone is a leading global policy analysis and regulatory due diligence firm with locations in Washington, DC, New York, Houston, London, Paris, Mumbai, and Sydney. As developments in Washington, London, Brussels, and other centers of government become more crucial to investment strategies, legislation, regulatory reforms, and new federal oversight are affecting industries in evolving ways. We advise institutional investors and companies on how changes in state, federal, and international policy impact investments. Capstone has established leading coverage of public policy investments affecting financial and business services, energy and environment, healthcare, national security, TMT, and more. Our professionals analyze policy to uncover risks, opportunities and, in the process, unique business and investment strategies for our clients.
Contact: Daniel Kruger, Capstone
Phone: 917-566-8220
Email: news@capstonedc.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/capstone-llc-releases-2026-healthcare-outlook-policy-shifts-and-market-restructuring-to-reshape-provider-payor-and-pharma-dynamics-302675594.html
SOURCE CAPSTONE LLC
